> Archemix and Isis Pharmaceuticals have inked a deal to collaborate on aptamer drug discovery and development. Release
> WuXi PharmaTech can bank on a successful IPO. Its shares jumped 38 percent on its opening after it priced above expectations. Release
> An FDA ruling is looming for Wyeth's schizophrenia drug bifeprunox. Report
> A team of investigators says a new trial of an experimental stroke drug has demonstrated no effect. Report
> Jordan's Hikma Pharmaceuticals is buying Alkan Pharma in Egypt for $60.5 million. Report
> American Oriental Bioengineering is buying Guangxi Boke Pharmaceutical Company for $40 million. Release
> India's Biocon has inked a deal to commercialize Abraxis' Abraxane in India. Report
> Avexa says it is ready to launch a late-stage trial of ATC. Release
And Finally… Britain's rising rates of cancer are being linked to lifestyle choices like sunbathing, drinking and smoking. Report